1. Home
  2. RDHL vs NURO Comparison

RDHL vs NURO Comparison

Compare RDHL & NURO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDHL
  • NURO
  • Stock Information
  • Founded
  • RDHL 2009
  • NURO 1996
  • Country
  • RDHL Israel
  • NURO United States
  • Employees
  • RDHL N/A
  • NURO N/A
  • Industry
  • RDHL Biotechnology: Pharmaceutical Preparations
  • NURO Medical/Dental Instruments
  • Sector
  • RDHL Health Care
  • NURO Health Care
  • Exchange
  • RDHL Nasdaq
  • NURO Nasdaq
  • Market Cap
  • RDHL 8.2M
  • NURO 8.2M
  • IPO Year
  • RDHL N/A
  • NURO N/A
  • Fundamental
  • Price
  • RDHL $5.85
  • NURO $4.38
  • Analyst Decision
  • RDHL
  • NURO
  • Analyst Count
  • RDHL 0
  • NURO 0
  • Target Price
  • RDHL N/A
  • NURO N/A
  • AVG Volume (30 Days)
  • RDHL 11.1K
  • NURO 21.7K
  • Earning Date
  • RDHL 08-29-2024
  • NURO 02-20-2025
  • Dividend Yield
  • RDHL N/A
  • NURO N/A
  • EPS Growth
  • RDHL N/A
  • NURO N/A
  • EPS
  • RDHL N/A
  • NURO N/A
  • Revenue
  • RDHL $3,707,000.00
  • NURO $3,767,764.00
  • Revenue This Year
  • RDHL $224.90
  • NURO N/A
  • Revenue Next Year
  • RDHL $82.69
  • NURO N/A
  • P/E Ratio
  • RDHL N/A
  • NURO N/A
  • Revenue Growth
  • RDHL N/A
  • NURO N/A
  • 52 Week Low
  • RDHL $5.41
  • NURO $2.66
  • 52 Week High
  • RDHL $20.28
  • NURO $4.73
  • Technical
  • Relative Strength Index (RSI)
  • RDHL 40.41
  • NURO 67.97
  • Support Level
  • RDHL $5.80
  • NURO $4.16
  • Resistance Level
  • RDHL $6.26
  • NURO $4.40
  • Average True Range (ATR)
  • RDHL 0.31
  • NURO 0.09
  • MACD
  • RDHL 0.01
  • NURO 0.03
  • Stochastic Oscillator
  • RDHL 19.33
  • NURO 95.24

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company also commercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.

About NURO NeuroMetrix Inc.

NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment being Medical equipment and consumables.

Share on Social Networks: